1. Potent inhibition of human gastric cancer by HER2-directed induction of apoptosis with anti-HER2 antibody and caspase-3 fusion protein
- Author
-
Kaichun Wu, Yan-Ming Xu, Dexin Zhang, Si-Yi Chen, Lili Liu, An-Gang Yang, Xuegang Guo, Jie Liang, Lin-Tao Jia, Huihong Zhai, Peng-Tao Zhao, Hongbo Zhang, Lin Xia, and Daiming Fan
- Subjects
Receptor, ErbB-2 ,medicine.drug_class ,Recombinant Fusion Proteins ,Drug Evaluation, Preclinical ,Mice, Nude ,Antineoplastic Agents ,Apoptosis ,Biology ,Monoclonal antibody ,Mice ,chemistry.chemical_compound ,Stomach Neoplasms ,Tumor Cells, Cultured ,medicine ,Animals ,Humans ,Mice, Inbred BALB C ,Oncogene ,Caspase 3 ,Gastroenterology ,Antibodies, Monoclonal ,Cancer ,medicine.disease ,Xenograft Model Antitumor Assays ,Fusion protein ,Molecular biology ,Neoplasm Proteins ,chemistry ,Cancer cell ,biology.protein ,Growth inhibition ,Antibody - Abstract
Background and aims HER2 , an oncogene, has been found to be over-expressed in 10โ40% of human gastric carcinomas. The aims of this study were to investigate if a fusion protein consisting of anti-HER2 sFv and constitutively active caspase-3 was capable of inducing apoptosis in HER2-expressing human gastric cancer cells and blocking the growth of human gastric cancer xenografts in nude mice. Methods NIH3T3 cells stably transduced with the pcDNA3.1-HER-PE-CP3 recombinant plasmid containing a secretion signal, a single-chain anti-HER2 monoclonal antibody fragment, a Pseudomonas exotoxin A translocation domain and a constitutively active caspase-3 molecule were used to induce apoptosis in human gastric cancer cells both in vitro and in vivo. Immunofluorescence staining and western blotting were used to examine the expression of the recombinant protein HER-PE-CP3. Apoptosis was determined by flow cytometry and TUNEL assay. Results Co-cultivation of HER-PE-CP3/ NIH3T3 with human gastric cancer cells led to internalisation of HER-PE-CP3 and apoptosis in HER2-expressing human gastric cancer cells but not in HER2-negative cancer cells. Inoculation of HER-PE-CP3/NIH3T3 in nude mice resulted in potent inhibition of human gastric cancer xenografts and much prolonged survival time of the tumour-bearing mice compared with the control. Significantly more apoptotic cells were detected in xenografts in mice receiving HER-PE-CP3/NIH3T3 than in control mice. Conclusions The HER-PE-CP3 chimeric molecule could induce selective apoptosis and potent growth inhibition of HER2-positive human gastric cancer cells and might represent a novel HER2-directed treatment option for human gastric cancer.
- Published
- 2009
- Full Text
- View/download PDF